Shalini Sharp, CFO & Senior Vice President at Ultragenyx Pharmaceutical Inc. (RARE), sold 12,000 shares at $60.98 ($737K) on 2016-10-19, disclosed to the SEC on 2016-10-21.
Open-market sale of $737k RARE by CFO & Senior Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.98 | 5,068 | $309K | 41.9% |
| 2 | $61.71 | 6,932 | $428K | 58.1% |
| Total | $61.40 avg | 12,000 | $737K | 100% |
| Filing → |
| RARE | SELL | 2020-08-19 | $2.5M | — | Filing → |
| RARE | SELL | 2020-06-05 | $1.9M | — | Filing → |
| RARE | SELL | 2020-05-20 | $4.3M | — | Filing → |